Ketek loses two of three indications
The FDA today announced revisions to the labeling of Sanofi-Aventis’ antibiotic Ketek, restricting use of the drug only to treat ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.